SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Abhay A. Shukla, Manish Jha, Thomas Birchfield, Shibani Mukherjee, Kelly Gleason, Salim Abdisalaam, Aroumougame Asaithamby, Beverley Adams-Huet, Carol A. Tamminga, Subroto Ghose, COMT val158met polymorphism and molecular alterations in the human dorsolateral prefrontal cortex: Differences in controls and in schizophrenia, Schizophrenia Research, 2016, 173, 1-2, 94

    CrossRef

  2. 2
    Barbara Juarez, Ming-Hu Han, Diversity of Dopaminergic Neural Circuits in Response to Drug Exposure, Neuropsychopharmacology, 2016,

    CrossRef

  3. 3
    Jessica L. Ihne, Natalie M. Gallagher, Marie Sullivan, Joseph H. Callicott, Adam E. Green, Is less really more: Does a prefrontal efficiency genotype actually confer better performance when working memory becomes difficult?, Cortex, 2016, 74, 79

    CrossRef

  4. 4
    Nathaniel J. Blanco, Bradley C. Love, Jessica A. Cooper, John E. McGeary, Valerie S. Knopik, W. Todd Maddox, A frontal dopamine system for reflective exploratory behavior, Neurobiology of Learning and Memory, 2015, 123, 84

    CrossRef

  5. 5
    Young Ho Lee, Jae-Hoon Kim, Gwan Gyu Song, Association between the COMT Val158Met polymorphism and fibromyalgia susceptibility and fibromyalgia impact questionnaire score: a meta-analysis, Rheumatology International, 2015, 35, 1, 159

    CrossRef

  6. 6
    Katherine E. Rooney, lane J. Wallace, Computational modeling of extracellular dopamine kinetics suggests low probability of neurotransmitter release, Synapse, 2015, 69, 11
  7. 7
    Sara Sannino, Alessandro Gozzi, Antonio Cerasa, Fabrizio Piras, Diego Scheggia, Francesca Managò, Mario Damiano, Alberto Galbusera, Lucy C. Erickson, Davide De Pietri Tonelli, Angelo Bifone, Sotirios A. Tsaftaris, Carlo Caltagirone, Daniel R. Weinberger, Gianfranco Spalletta, Francesco Papaleo, COMT Genetic Reduction Produces Sexually Divergent Effects on Cortical Anatomy and Working Memory in Mice and Humans, Cerebral Cortex, 2015, 25, 9, 2529

    CrossRef

  8. 8
    Maximiliano Rapanelli, Luciana Romina Frick, Anabel M.M. Miguelez Fernández, B. Silvano Zanutto, Dopamine bioavailability in the mPFC modulates operant learning performance in rats: An experimental study with a computational interpretation, Behavioural Brain Research, 2015, 280, 92

    CrossRef

  9. 9
    James MacKillop, Joshua C. Gray, L. Cinnamon Bidwell, Warren K. Bickel, Christine E. Sheffer, John E. McGeary, Genetic influences on delay discounting in smokers: examination of a priori candidates and exploration of dopamine-related haplotypes, Psychopharmacology, 2015, 232, 20, 3731

    CrossRef

  10. 10
    Katharina Schmack, Hannes Rössler, Maria Sekutowicz, Eva J. Brandl, Daniel J. Müller, Predrag Petrovic, Philipp Sterzer, Linking unfounded beliefs to genetic dopamine availability, Frontiers in Human Neuroscience, 2015, 9,

    CrossRef

  11. 11
    Scott T. Harrison, Michael S. Poslusney, James J. Mulhearn, Zhijian Zhao, Nathan R. Kett, Jeffrey W. Schubert, Jeffrey Y. Melamed, Timothy J. Allison, Sangita B. Patel, John M. Sanders, Sujata Sharma, Robert F. Smith, Dawn L. Hall, Ronald G. Robinson, Nancy A. Sachs, Pete H. Hutson, Scott E. Wolkenberg, James C. Barrow, Synthesis and Evaluation of Heterocyclic Catechol Mimics as Inhibitors of Catechol-O-methyltransferase (COMT), ACS Medicinal Chemistry Letters, 2015, 6, 3, 318

    CrossRef

  12. 12
    Ashley A. Vena, Rueben A. Gonzales, Temporal Profiles Dissociate Regional Extracellular Ethanol versus Dopamine Concentrations, ACS Chemical Neuroscience, 2015, 6, 1, 37

    CrossRef

  13. 13
    Tatiana A. Shnitko, Donita L. Robinson, Anatomical and pharmacological characterization of catecholamine transients in the medial prefrontal cortex evoked by ventral tegmental area stimulation, Synapse, 2014, 68, 4
  14. 14
    Doron Gothelf, Amanda J. Law, Amos Frisch, Jingshan Chen, Omer Zarchi, Elena Michaelovsky, Renee Ren-Patterson, Barbara K. Lipska, Miri Carmel, Bhaskar Kolachana, Abraham Weizman, Daniel R. Weinberger, Biological Effects of COMT Haplotypes and Psychosis Risk in 22q11.2 Deletion Syndrome, Biological Psychiatry, 2014, 75, 5, 406

    CrossRef

  15. 15
    Lisheng Du, Zul Merali, Michael O. Poulter, Miklós Palkovits, Gábor Faludi, Hymie Anisman, Catechol-O-methyltransferase Val158Met polymorphism and altered COMT gene expression in the prefrontal cortex of suicide brains, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2014, 50, 178

    CrossRef

  16. 16
    Young Ho Lee, Gwan Gyu Song, COMT Val158Met and PPARγ Pro12Ala polymorphisms and susceptibility to Alzheimer’s disease: a meta-analysis, Neurological Sciences, 2014, 35, 5, 643

    CrossRef

  17. 17
    Nay Chi Htun, Koichi Miyaki, Chenxi Zhao, Masaaki Muramatsu, Noriko Sato, Epistasis effects of COMT and MTHFR on inter-individual differences in mental health: Under the inverted U-shaped prefrontal dopamine model, Biochemical and Biophysical Research Communications, 2014, 451, 4, 574

    CrossRef

  18. 18
    F Papaleo, M C Burdick, J H Callicott, D R Weinberger, Epistatic interaction between COMT and DTNBP1 modulates prefrontal function in mice and in humans, Molecular Psychiatry, 2014, 19, 3, 311

    CrossRef

  19. 19
    Christopher T. Smith, Theresa Swift-Scanlan, Charlotte A. Boettiger, Genetic Polymorphisms Regulating Dopamine Signaling in the Frontal Cortex Interact to Affect Target Detection under High Working Memory Load, Journal of Cognitive Neuroscience, 2014, 26, 2, 395

    CrossRef

  20. 20
    Floor van Heesch, Jolanda Prins, Jan Pieter Konsman, Gerdien A.H. Korte-Bouws, Koen G.C. Westphal, Joanna Rybka, Berend Olivier, Aletta D. Kraneveld, S. Mechiel Korte, Lipopolysaccharide increases degradation of central monoamines: An in vivo microdialysis study in the nucleus accumbens and medial prefrontal cortex of mice, European Journal of Pharmacology, 2014, 725, 55

    CrossRef

  21. 21
    G. Gründer, T. Bartsch, Neuroenhancement, Der Nervenarzt, 2014, 85, 12, 1536

    CrossRef

  22. 22
    Hongjuan Sun, Fangfen Yuan, Xuemei Shen, Guanglian Xiong, Jing Wu, Role of COMT in ADHD: a Systematic Meta-Analysis, Molecular Neurobiology, 2014, 49, 1, 251

    CrossRef

  23. 23
    Marta Marquie, Joseph J Locascio, Dorene M Rentz, J Alex Becker, Trey Hedden, Keith A Johnson, John H Growdon, Stephen N Gomperts, Striatal and extrastriatal dopamine transporter levels relate to cognition in Lewy body diseases: an 11C altropane positron emission tomography study, Alzheimer's Research & Therapy, 2014, 6, 5-8

    CrossRef

  24. 24
    M. Daubaras, G. Dal Bo, C. Flores, Target-dependent expression of the netrin-1 receptor, UNC5C, in projection neurons of the ventral tegmental area, Neuroscience, 2014, 260, 36

    CrossRef

  25. 25
    Aqilah M. McCane, Cristine L. Czachowski, Christopher C. Lapish, Tolcapone Suppresses Ethanol Intake in Alcohol-Preferring Rats Performing a Novel Cued Access Protocol, Alcoholism: Clinical and Experimental Research, 2014, 38, 9
  26. 26
    Susan R. Sesack, The Synapse, 2014,

    CrossRef

  27. 27
    M. R. Lee, C. L. Gallen, T. J. Ross, P. Kurup, B. J. Salmeron, C. A. Hodgkinson, D. Goldman, E. A. Stein, M. A. Enoch, A preliminary study suggests that nicotine and prefrontal dopamine affect cortico-striatal areas in smokers with performance feedback, Genes, Brain and Behavior, 2013, 12, 5
  28. 28
    I. Heitland, J.L. Kenemans, R.S. Oosting, J.M.P. Baas, K.B.E. Böcker, Auditory event-related potentials (P3a, P3b) and genetic variants within the dopamine and serotonin system in healthy females, Behavioural Brain Research, 2013, 249, 55

    CrossRef

  29. 29
    Mary Katherine Kelm, Charlotte A. Boettiger, Effects of Acute Dopamine Precusor Depletion on Immediate Reward Selection Bias and Working Memory Depend on Catechol-O-methyltransferase Genotype, Journal of Cognitive Neuroscience, 2013, 25, 12, 2061

    CrossRef

  30. 30
    Zachary Brodnik, Manda Double, George E. Jaskiw, Presynaptic regulation of extracellular dopamine levels in the medial prefrontal cortex and striatum during tyrosine depletion, Psychopharmacology, 2013, 227, 2, 363

    CrossRef

  31. 31
    Niki Antypa, Antonio Drago, Alessandro Serretti, The role of COMT gene variants in depression: Bridging neuropsychological, behavioral and clinical phenotypes, Neuroscience & Biobehavioral Reviews, 2013, 37, 8, 1597

    CrossRef

  32. 32
    Samantha Brooks, Mathias Rask-Andersen, Christian Benedict, Helgi Schiöth, A debate on current eating disorder diagnoses in light of neurobiological findings: is it time for a spectrum model?, BMC Psychiatry, 2012, 12, 1, 76

    CrossRef

  33. 33
    Nadia Schendzielorz, Pekka T. Männistö, Maria Karayiorgou, Joseph A. Gogos, Atso Raasmaja, A Transient Inhibition and Permanent Lack of Catechol-O-Methyltransferase have Minor Effects on Feeding Pattern of Female Rodents, Basic & Clinical Pharmacology & Toxicology, 2012, 110, 4
  34. 34
    Christopher T. Smith, Charlotte A. Boettiger, Age modulates the effect of COMT genotype on delay discounting behavior, Psychopharmacology, 2012, 222, 4, 609

    CrossRef

  35. 35
    Anne Tammimäki, Pekka T. Männistö, Catechol-O-methyltransferase gene polymorphism and chronic human pain, Pharmacogenetics and Genomics, 2012, 22, 9, 673

    CrossRef

  36. 36
    Ronald G. Robinson, Sean M. Smith, Scott E. Wolkenberg, Monika Kandebo, Lihang Yao, Christopher R. Gibson, Scott T. Harrison, Stacey Polsky-Fisher, James C. Barrow, Peter J. Manley, James J. Mulhearn, Kausik K. Nanda, Jeffrey W. Schubert, B. Wesley Trotter, Zhijian Zhao, John M. Sanders, Robert F. Smith, Debra McLoughlin, Sujata Sharma, Dawn L. Hall, Tiffany L. Walker, Jennifer L. Kershner, Neetesh Bhandari, Pete H. Hutson, Nancy A. Sachs, Characterization of Non-Nitrocatechol Pan and Isoform Specific Catechol-O-methyltransferase Inhibitors and Substrates, ACS Chemical Neuroscience, 2012, 3, 2, 129

    CrossRef

  37. 37
    Philip Asherson, Thomas S. Price, Commentary: Replication, replication, replication: the continued need to substantiate GxE effects in child psychopathology – a response to Laucht et al. (2012), Journal of Child Psychology and Psychiatry, 2012, 53, 4
  38. 38
    Michael R. Hunsaker, Comprehensive neurocognitive endophenotyping strategies for mouse models of genetic disorders, Progress in Neurobiology, 2012, 96, 2, 220

    CrossRef

  39. 39
    Márcio Gerhardt Soeiro-de-Souza, Rodrigo Machado-Vieira, Danielle Soares Bio, Carolina Martins Do Prado, Ricardo Alberto Moreno, COMT polymorphisms as predictors of cognitive dysfunction during manic and mixed episodes in bipolar I disorder, Bipolar Disorders, 2012, 14, 5
  40. 40
    Andre F. Marquand, Owen G. O'Daly, Sara De Simoni, David C. Alsop, R. Paul Maguire, Steven C.R. Williams, Fernando O. Zelaya, Mitul A. Mehta, Dissociable effects of methylphenidate, atomoxetine and placebo on regional cerebral blood flow in healthy volunteers at rest: A multi-class pattern recognition approach, NeuroImage, 2012, 60, 2, 1015

    CrossRef

  41. 41
    H. Y. Tan, A. G. Chen, B. Kolachana, J. A. Apud, V. S. Mattay, J. H. Callicott, Q. Chen, D. R. Weinberger, Effective connectivity of AKT1-mediated dopaminergic working memory networks and pharmacogenetics of anti-dopaminergic treatment, Brain, 2012, 135, 5, 1436

    CrossRef

  42. 42
    F. Papaleo, L. Erickson, G. Liu, J. Chen, D. R. Weinberger, Effects of sex and COMT genotype on environmentally modulated cognitive control in mice, Proceedings of the National Academy of Sciences, 2012, 109, 49, 20160

    CrossRef

  43. 43
    Francesco Papaleo, Barbara K. Lipska, Daniel R. Weinberger, Mouse models of genetic effects on cognition: Relevance to schizophrenia, Neuropharmacology, 2012, 62, 3, 1204

    CrossRef

  44. 44
    Carlos Eduardo Macedo, Marie-Josée Angst, Serge Gobaille, Carmen Schleef, Blandine Guignard, Thierry Guiberteau, Alain Louilot, Guy Sandner, Prefrontal dopamine release and sensory-specific satiety altered in rats with neonatal ventral hippocampal lesions, Behavioural Brain Research, 2012, 231, 1, 97

    CrossRef

  45. 45
    Rodolfo Bongiovanni, Abby N. Kyser, George E. Jaskiw, Tyrosine depletion lowers in vivo DOPA synthesis in ventral hippocampus, European Journal of Pharmacology, 2012, 696, 1-3, 70

    CrossRef

  46. 46
    Vincent Leviel, Dopamine release mediated by the dopamine transporter, facts and consequences, Journal of Neurochemistry, 2011, 118, 4
  47. 47
    Oleg Kamburl, Pekka T. Männistöl, Anne M. Pusal, Mikko Käenmäkil, Eija A. Kalsol, Vesa K. Kontinenl, Nitecapone reduces development and symptoms of neuropathic pain after spinal nerve ligation in rats, European Journal of Pain, 2011, 15, 7
  48. 48
    Zsofia Nemoda, Anna Szekely, Maria Sasvari-Szekely, Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood, Neuroscience & Biobehavioral Reviews, 2011, 35, 8, 1665

    CrossRef

  49. 49
    Erkki Nissinen, Pekka T. Männistö, Basic Aspects of Catechol-O-Methyltransferase and the Clinical Applications of its Inhibitors, 2010,

    CrossRef

  50. 50
    Oleg Kambur, Pekka T. Männistö, Basic Aspects of Catechol-O-Methyltransferase and the Clinical Applications of its Inhibitors, 2010,

    CrossRef